Cargando…
TPH1 A218C polymorphism and temperament in major depression
BACKGROUND: In major depression, one of the candidate genes possibly affecting the risk and severity of symptoms has been found to be tryptophan hydroxylase (TPH1). Variation in treatment response to antidepressive agents according to TPH1 genotype has also been found in several studies. However, th...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3704284/ https://www.ncbi.nlm.nih.gov/pubmed/23597148 http://dx.doi.org/10.1186/1471-244X-13-118 |
_version_ | 1782275979450777600 |
---|---|
author | Andre, Kadri Kampman, Olli Viikki, Merja Illi, Ari Setälä-Soikkeli, Eija Poutanen, Outi Mononen, Nina Leinonen, Esa Lehtimäki, Terho |
author_facet | Andre, Kadri Kampman, Olli Viikki, Merja Illi, Ari Setälä-Soikkeli, Eija Poutanen, Outi Mononen, Nina Leinonen, Esa Lehtimäki, Terho |
author_sort | Andre, Kadri |
collection | PubMed |
description | BACKGROUND: In major depression, one of the candidate genes possibly affecting the risk and severity of symptoms has been found to be tryptophan hydroxylase (TPH1). Variation in treatment response to antidepressive agents according to TPH1 genotype has also been found in several studies. However, the relationship between temperament and TPH1 genotype in major depression is poorly understood, as only one study has been published so far. There are no earlier studies on the interaction between temperament traits, antidepressive medication response and TPH1 genotype. This interaction was studied in 97 subjects with major depression treated for six weeks with selective serotonine reuptake inhibitors. METHODS: Temperament dimensions Harm Avoidance (HA), Novelty Seeking (NS), Reward Dependence (RD) and Persistence (P) scores at baseline (1) and endpoint (2) were rated with the Temperament and Character Inventory (TCI) and compared between TPH1 A218C genotypes. Multivariate analysis of co-variance (MANCOVA) was used to analyze the interaction between the TPH1 genotype, treatment response and the different temperament dimensions at baseline and endpoint. In the analysis model, treatment response was used as a covariate and TPH1 genotype as a factor. A post hoc analysis for an interaction between remission status and TPH1 A218C genotype at endpoint HA level was also performed. RESULTS: The number of TPH1 A-alleles was associated with increasing levels in NS1 and NS2 scores and decreasing levels in HA1 and HA2 scores between TPH1 A218C genotypes. In the MANCOVA model, TPH1 genotype and treatment response had an interactive effect on both HA1 and HA2 scores, and to a lesser degree on NS2 scores. Additionally, an interaction between remission status and TPH1 A218C genotype was found to be associated with endpoint HA score, with a more marked effect of the interaction between CC genotype and remission status compared to A-allele carriers. CONCLUSIONS: Our results suggest that in acute depression TPH1 A218C polymorphism and specifically the CC genotype together with the information on remission or treatment response differentiates between different temperament profiles and their changes. |
format | Online Article Text |
id | pubmed-3704284 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-37042842013-07-09 TPH1 A218C polymorphism and temperament in major depression Andre, Kadri Kampman, Olli Viikki, Merja Illi, Ari Setälä-Soikkeli, Eija Poutanen, Outi Mononen, Nina Leinonen, Esa Lehtimäki, Terho BMC Psychiatry Research Article BACKGROUND: In major depression, one of the candidate genes possibly affecting the risk and severity of symptoms has been found to be tryptophan hydroxylase (TPH1). Variation in treatment response to antidepressive agents according to TPH1 genotype has also been found in several studies. However, the relationship between temperament and TPH1 genotype in major depression is poorly understood, as only one study has been published so far. There are no earlier studies on the interaction between temperament traits, antidepressive medication response and TPH1 genotype. This interaction was studied in 97 subjects with major depression treated for six weeks with selective serotonine reuptake inhibitors. METHODS: Temperament dimensions Harm Avoidance (HA), Novelty Seeking (NS), Reward Dependence (RD) and Persistence (P) scores at baseline (1) and endpoint (2) were rated with the Temperament and Character Inventory (TCI) and compared between TPH1 A218C genotypes. Multivariate analysis of co-variance (MANCOVA) was used to analyze the interaction between the TPH1 genotype, treatment response and the different temperament dimensions at baseline and endpoint. In the analysis model, treatment response was used as a covariate and TPH1 genotype as a factor. A post hoc analysis for an interaction between remission status and TPH1 A218C genotype at endpoint HA level was also performed. RESULTS: The number of TPH1 A-alleles was associated with increasing levels in NS1 and NS2 scores and decreasing levels in HA1 and HA2 scores between TPH1 A218C genotypes. In the MANCOVA model, TPH1 genotype and treatment response had an interactive effect on both HA1 and HA2 scores, and to a lesser degree on NS2 scores. Additionally, an interaction between remission status and TPH1 A218C genotype was found to be associated with endpoint HA score, with a more marked effect of the interaction between CC genotype and remission status compared to A-allele carriers. CONCLUSIONS: Our results suggest that in acute depression TPH1 A218C polymorphism and specifically the CC genotype together with the information on remission or treatment response differentiates between different temperament profiles and their changes. BioMed Central 2013-04-18 /pmc/articles/PMC3704284/ /pubmed/23597148 http://dx.doi.org/10.1186/1471-244X-13-118 Text en Copyright © 2013 Andre et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Andre, Kadri Kampman, Olli Viikki, Merja Illi, Ari Setälä-Soikkeli, Eija Poutanen, Outi Mononen, Nina Leinonen, Esa Lehtimäki, Terho TPH1 A218C polymorphism and temperament in major depression |
title | TPH1 A218C polymorphism and temperament in major depression |
title_full | TPH1 A218C polymorphism and temperament in major depression |
title_fullStr | TPH1 A218C polymorphism and temperament in major depression |
title_full_unstemmed | TPH1 A218C polymorphism and temperament in major depression |
title_short | TPH1 A218C polymorphism and temperament in major depression |
title_sort | tph1 a218c polymorphism and temperament in major depression |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3704284/ https://www.ncbi.nlm.nih.gov/pubmed/23597148 http://dx.doi.org/10.1186/1471-244X-13-118 |
work_keys_str_mv | AT andrekadri tph1a218cpolymorphismandtemperamentinmajordepression AT kampmanolli tph1a218cpolymorphismandtemperamentinmajordepression AT viikkimerja tph1a218cpolymorphismandtemperamentinmajordepression AT illiari tph1a218cpolymorphismandtemperamentinmajordepression AT setalasoikkelieija tph1a218cpolymorphismandtemperamentinmajordepression AT poutanenouti tph1a218cpolymorphismandtemperamentinmajordepression AT mononennina tph1a218cpolymorphismandtemperamentinmajordepression AT leinonenesa tph1a218cpolymorphismandtemperamentinmajordepression AT lehtimakiterho tph1a218cpolymorphismandtemperamentinmajordepression |